Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Frontiers Emerging roles of the gut microbiota in cancer immunotherapy

T-cell engineering strategies for tumors with low antigen density, and T- cell survival in the immunosuppressive tumor microenvironment of relapsed/refractory diffuse large B-cell lymphoma – ScienceOpen

Potential links between the microbiota and T cell immunity determine the tumor cell fate

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy: Molecular Therapy

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology

Potential links between the microbiota and T cell immunity determine the tumor cell fate

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Cancers, Free Full-Text

Cancers, Free Full-Text

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and